Agile Therapeutics Inc (AGRX)
0.3678
-0.02
(-4.62%)
USD |
OTCM |
Apr 17, 15:44
Agile Therapeutics Cash from Investing (TTM): 0.00 for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | -0.007M |
December 31, 2022 | -0.133M |
September 30, 2022 | -0.188M |
June 30, 2022 | 4.747M |
March 31, 2022 | 23.15M |
December 31, 2021 | 39.46M |
September 30, 2021 | 46.87M |
June 30, 2021 | 41.93M |
March 31, 2021 | -24.34M |
December 31, 2020 | -40.69M |
September 30, 2020 | -48.11M |
June 30, 2020 | -48.14M |
March 31, 2020 | -0.262M |
December 31, 2019 | -0.098M |
September 30, 2019 | -0.03M |
June 30, 2019 | -0.002M |
March 31, 2019 | -0.042M |
December 31, 2018 | -0.318M |
Date | Value |
---|---|
September 30, 2018 | -0.86M |
June 30, 2018 | -1.179M |
March 31, 2018 | -1.584M |
December 31, 2017 | -1.313M |
September 30, 2017 | -0.777M |
June 30, 2017 | -0.461M |
March 31, 2017 | -0.034M |
December 31, 2016 | -0.031M |
September 30, 2016 | -0.027M |
June 30, 2016 | -0.035M |
March 31, 2016 | -0.103M |
December 31, 2015 | -0.29M |
September 30, 2015 | -0.3417M |
June 30, 2015 | -0.3643M |
March 31, 2015 | -0.2839M |
December 31, 2014 | -0.096M |
September 30, 2014 | -0.0951M |
June 30, 2014 | -0.3182M |
March 31, 2014 | -1.906M |
December 31, 2013 | -4.945M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-48.14M
Minimum
Jun 2020
46.87M
Maximum
Sep 2021
-0.3077M
Average
-0.007M
Median
Mar 2023
Cash from Investing (TTM) Benchmarks
Altimmune Inc | 13.73M |
iBio Inc | 8.285M |
Ampio Pharmaceuticals Inc | -- |
Oragenics Inc | -0.9363M |
Actinium Pharmaceuticals Inc | -0.153M |